Visceral leishmaniasis (VL) is a vector-borne disease caused by the digenetic protozoan
parasite Leishmania donovani complex. So far there is no effective vaccine available …

Leishmaniasis is a parasitic disease with no effective vaccine still now. Globally, it has
affected millions of people, precisely in the undeveloped and developing countries. The …

Aim: The assessment of the antileishmanial potential of 22 vanillin-containing 1, 2, 3-triazole
derivatives against Leishmania braziliensis is reported. Materials & methods: Initial …

This study details the preparation, antileishmanial assay, and in silico analysis of twenty 2-
hydroxy-3-(1, 2, 3-triazolyl) propyl vanillin derivatives. These compounds were synthesized …

The search for new herbal-based immune-pharmacological agents for the treatment of
several infectious diseases caused by fungi, bacteria, and protozoa, such as leishmaniasis …

Leishmaniasis is endemic anthropozoonosis considered to be a severe public health
problem. The treatment with pentavalent antimonials presents high toxicity motivating the …

Leishmaniasis is an infectious parasitic disease caused by Leishmania. There are more
than 21 species that cause human infections, and 12 million people worldwide are infected …

Objective: Recently, the COVID-19 (coronavirus disease) pandemic caused by SARSCoV-2
(severe acute respiratory syndrome coronavirus) gave rise to a public health emergency …

Background: Leishmaniasis is a neglected tropical disease associated with several clinical
manifestations, including cutaneous, mucocutaneous, and visceral forms. As currently …

Leishmaniasis affects the poorest of the poor across the globe. The present treatment is not
quite effective. The troubling increase in drug resistance and the inaccessibility of an …